E16.A2 — Hypoglycemia level 2
Is E16.A2 billable?
Yes — E16.A2 is billable for FY2027. E16.A2 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E16.A2 may be submitted for encounters from October 1, 2026 through September 30, 2027.
E16.A2 at a glance
| Code | E16.A2 |
|---|---|
| Description | Hypoglycemia level 2 |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does E16.A2 group to?
E16.A2 sits in MDC 10 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 643Endocrine Disorders with MCCmedical
- 644Endocrine Disorders with CCmedical
- 645Endocrine Disorders without CC/MCCmedical
How is E16.A2 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to E16.A2. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Hypoglycemia › level › 2 (spontaneous)
- Decrease › blood › glucose › level 2 (d)
Inclusion terms
Alternative wording in documentation that is classified to E16.A2.
- Decreased blood glucose level 2
Excludes1 — never code together — inherited from Chapter 4
The conditions below can never be reported together with E16.A2 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
How long has E16.A2 existed?
E16.A2 first appears in FY2025.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.